Sumitomo Mitsui DS Asset Management Company, Ltd
Position in RPRX — Royalty Pharma plc
CIK 1411530
TOKYO, M0
Position in RPRX
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$11,593,313
+$4,739,456 QoQ
Shares Held
206,765
+44.7% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#143
of 641 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sumitomo Mitsui DS Asset Management Company, Ltd holds $66,797,123 across 9 Biotechnology names. RPRX ranks #2 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
63,330 | $31,457,910 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
206,765 | $11,593,313 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,260 | $8,891,680 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
18,366 | $5,528,716 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
17,140 | $3,209,979 | |
| 6 | INCY |
Incyte Corp
|
23,037 | $2,611,474 | |
| 7 | INSM |
INSMED Inc
|
22,303 | $2,377,945 | |
| 8 | MRNA |
Moderna, Inc.
|
11,938 | $836,018 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,593,313 | 206,765 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $6,853,857 | 142,878 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,672,609 | 43,287 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,518,168 | 43,032 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $1,535,958 | 42,630 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $1,301,171 | 41,798 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $718,948 | 28,183 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $797,297 | 28,183 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $743,185 | 28,183 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $855,553 | 28,171 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $792,896 | 28,227 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $766,080 | 28,227 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $869,665 | 28,291 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,019,324 | 28,291 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $866,041 | 21,914 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $880,504 | 21,914 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $809,227 | 19,249 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $749,941 | 19,249 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $767,072 | 19,249 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $290,312 | 8,033 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $331,486 | 8,087 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $352,754 | 8,087 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $318,117 | 6,356 | Shares | Sole | 2021-02-02 | |
| No filing history on record for this holder in this stock. | ||||||